<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>i̇st tıp fak derg</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Journal of Istanbul Faculty of Medicine</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">1305-6441</issn>
                                                                                            <publisher>
                    <publisher-name>Istanbul University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.26650/IUITFD.1074354</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Health Care Administration</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Sağlık Kurumları Yönetimi</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <article-title>EXPOSURE TO MELAMINE FROM THE EARLY POSTNATAL PERIOD CAUSES NEPROTOXICITY: A HISTOPATHOLOGIC AND ULTRASTRUCTURAL STUDY</article-title>
                                                                                                                                                                                                <trans-title-group xml:lang="tr">
                                    <trans-title>ERKEN POSTNATAL DÖNEMDEN İTİBAREN MELAMİN MARUZİYETİ NEFROTOKSİSİTEYE NEDEN OLUR: BİR HİSTOPATOLOJİK VE ULTRASÜTRÜKTÜREL ÇALIŞMA</trans-title>
                                </trans-title-group>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0003-3523-6542</contrib-id>
                                                                <name>
                                    <surname>Erişgin</surname>
                                    <given-names>Züleyha</given-names>
                                </name>
                                                                    <aff>Giresun Üniversitesi Tıp Fakültesi Histoloji ve Embriyoloji AD.</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-4267-9619</contrib-id>
                                                                <name>
                                    <surname>Mutlu</surname>
                                    <given-names>Hasan Serdar</given-names>
                                </name>
                                                                    <aff>GİRESUN ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20220706">
                    <day>07</day>
                    <month>06</month>
                    <year>2022</year>
                </pub-date>
                                        <volume>85</volume>
                                        <issue>3</issue>
                                        <fpage>433</fpage>
                                        <lpage>439</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20220216">
                        <day>02</day>
                        <month>16</month>
                        <year>2022</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20220517">
                        <day>05</day>
                        <month>17</month>
                        <year>2022</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 1916, Journal of Istanbul Faculty of Medicine</copyright-statement>
                    <copyright-year>1916</copyright-year>
                    <copyright-holder>Journal of Istanbul Faculty of Medicine</copyright-holder>
                </permissions>
            
                                                                                                <abstract><p>Objective: Melamine (mel), which is illegally added to formula to providing false-positive protein content, has caused acute renal failure in infants due to crystal formation. This study aimed to investigate the nephrotoxic effects of chronic low-dose mel exposure from the weaning period (supplementary food period).Materials and Methods: Eighteen female rats in the weaning period (21-days-old) were divided into three groups. A 0.1 ml saline was given to the control group by oral gavage (p.o). Fifty mg/kg mel was given to the second group and 75 mg/kg mel to the third group dissolved in 0.1 ml saline for twenty one days p.o.. At the end of the experiment, the animals were sacrificed, and histopathologic, morphometric, and ultrastructural analysis were performed on kidney tissues.Results: There was an inflammatory cell infiltration in the tubulointerstitial area, and no crystal formation was observed in either of the mel groups. In the 75 mg mel group, glomerular and tubular epithelial damage and significant increases in Bowman’s space were observed (p&amp;lt;0.05). In the ultrastructural analysis, the capillary lumen was closed due to endothelial enlargement, dilatation in the pedicles and hypertrophy in podocytes were found in the 75 mg group. Pedicles in the 50 mg group appeared to be enlarged more than the control group, but the capillary lumen was more open than the 75 mg group.Conclusion: The results show that low dose mel exposure causes kidney damage with increased doses from the early postnatal period.</p></abstract>
                                                                                                                                    <trans-abstract xml:lang="tr">
                            <p>Amaç: İllegal olarak mamalara yalancı yüksek pozitif protein içeriği için eklenen melamin (mel), bebeklerde kristal oluşumuna bağlı akut böbrek yetmezliğine neden olmuştur. Bu çalışmada süt kesme döneminden (ek besin dönemi) itibaren kronik düşük doz mel maruziyetinin nefrotoksik etkilerinin araştırılması amaçlandı.Gereç ve Yöntem: Süt kesim dönemindeki (21 günlük) 18 dişi sıçan üç gruba bölündü. Kontrol grubuna 0.1 ml serum fizyolojik oral gavajla (p.o) verildi. İkinci gruba 50 mg/kg mel, üçüncü gruba 75 mg/kg mel 0.1 ml serum fizyolojik ile çözülerek yirmi bir gün p.o. verildi. Deney sonunda hayvanlar sakrifiye edildi ve böbrek dokularında histopatolojik, morfometrik ve ultrasütrüktürel analiz yapıldı.Bulgular: Her iki mel grubunda tubulointerstisyel alanda inflamatuar hücre infiltrasyonu vardı ve kristal oluşumu gözlenmedi. Yetmiş beş mg mel grubunda glomerüler ve tübüler epitel hasarı ve Bowman boşluğunda önemli artışlar gözlendi (p&amp;lt;0.05). Yetmiş beş mg grubunda ultrasütrüktürel analizlerinde endotel genişlemesi nedeniyle kapiller lümenin kapandığı, pedisellerde dilatasyon ve podositlerde hipertrofi saptandı. Elli mg grubundaki pediseller kontrol grubuna göre daha fazla genişlemiş gibi görünüyordu. Elli mg grubunda, kapiller lümen 75 mg grubuna göre daha açıktı.Tartışma: Sonuç olarak, erken postanal dönemden itibaren düşük doz mel maruziyeti artan dozlarda böbrek hasarına neden olmaktadır.</p></trans-abstract>
                                                            
            
                                                            <kwd-group>
                                                    <kwd>Early postnatal period</kwd>
                                                    <kwd>  electron microscopy</kwd>
                                                    <kwd>  kidney</kwd>
                                                    <kwd>  melamin</kwd>
                                                    <kwd>  nephrotoxicity</kwd>
                                                    <kwd>  rat</kwd>
                                            </kwd-group>
                                                        
                                                                            <kwd-group xml:lang="tr">
                                                    <kwd>Erken postnatal dönem</kwd>
                                                    <kwd>  elektron mikroskopi</kwd>
                                                    <kwd>  böbrek</kwd>
                                                    <kwd>  melamin</kwd>
                                                    <kwd>  nefrotoksisite</kwd>
                                                    <kwd>  sıçan</kwd>
                                            </kwd-group>
                                                                                                            </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">1. Bolden AL, Rochester JR, Kwiatkowski CF. Melamine, beyond the kidney: A ubiquitous endocrine disruptor and neurotoxicant? Toxicol Lett 2017;280:181-9. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">2. Dobson RL, Motlagh S, Quijano M, Cambron RT, Baker TR, Pullen AM, et al. Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. Toxicol Sci 2008;106(1):251- 62. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">3. Brown CA, Jeong KS, Poppenga RH, Puschner B, Miller DM, Ellis AE, et al. Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J Vet Diagn Invest 2007;19(5):525-31. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">4. Dalal RP, Goldfarb DS. Melamine-related kidney stones and renal toxicity. Nat Rev Nephrol 2011;7(5):267-74. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">5. Zhou W, Jiang Y, Shi H, Dai Q, Liu J, Shen C, et al. The characteristics of immune system changes in children who ingested melamine-contaminated powdered formula in China. Int J Environ Health Res 2010;20(4):289-97. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">6. Hau AK, Kwan TH, Li PK. Melamine toxicity and the kidney. J Am Soc Nephrol 2009;20(2):245-50. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">7. Wen JG, Liu XJ, Wang ZM, Li TF, Wahlqvist ML. Melaminecontaminated milk formula and its impact on children. Asia Pac J Clin Nutr 2016;25(4):697-705. google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">8. Mast RW, Jeffcoat AR, Sadler BM, Kraska RC, Friedman MA. Metabolism, disposition and excretion of [14C] melamine in male Fischer 344 rats. Food Chem Toxicol 1983;21(6):807- 10. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">9. WHO. Toxicological and Health Aspects of Melamine and Cyanuric Acid. Report of a WHO Expert Meeting In collaboration with FAO Supported by Health Canada Health Canada, Ottawa, Canada, 1-4 December 2008, page 32. Available from:URL: https://apps.who.int/iris/ bitstream/handle/10665/44106/9789241597951_eng.pdf 1-4 December 2008 google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">10. Langman CB, Alon U, Ingelfinger J, Englund M, Saland JM, Somers MJ, et al. A position statement on kidney disease from powdered infant formula-based melamine exposure in Chinese infants. Pediatr Nephrol 2009;24(7):1263-6. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">11. Park D, Kim TK, Choi YJ, Lee SH, Bae DK, Yang G, et al. Increased nephrotoxicity after combined administration of melamine and cyanuric Acid in rats. Lab Anim Res 2011;27(1):25-8. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">12. Yasui T, Kobayashi T, Okada A, Hamamoto S, Hirose M, Mizuno K, et al. Long-term follow-up of nephrotoxicity in rats administered both melamine and cyanuric acid. BMC Res Notes 2014;7:87. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">13. Jacob CC, Reimschuessel R, Von Tungeln LS, Olson GR, Warbritton AR, Hattan DG, et al. Dose-response assessment of nephrotoxicity from a 7-day combined exposure to melamine and cyanuric acid in F344 rats. Toxicol Sci 2011;119 (2):391-7. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">14. Peerakietkhajorn S, Huipao N, Hiranyachattada S. Effects of melamine and cyanuric acid on renal function and structure in rats. Sains Malaysiana 2019;48(8):1721-8. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">15. Xie G, Zheng X, Qi X, Cao Y, Chi Y, Su M, et al. Metabonomic evaluation of melamine-induced acute renal toxicity in rats. J Proteome Res 2010;9(1):125-33. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">16. Gamboa da Costa G, Jacob CC, Von Tungeln LS, Hasbrouck NR, Olson GR, Hattan DG, et al. Dose-response assessment of nephrotoxicity from a twenty-eight-day combinedexposure to melamine and cyanuric acid in F344 rats. Toxicol Appl Pharmacol 2012;262(2):99-106. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">17. Schnackenberg LK, Sun J, Pence LM, Bhattacharyya S, Gamboa da Costa G, Beger RD. Metabolomics evaluation of hydroxyproline as a potential marker of melamine and cyanuric acid nephrotoxicity in male and female Fischer F344 rats. Food and Chem Toxicol 2012;50(11):3978-83. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">18. Suchý P, Straková E, Herzig I, Staňa J, Kalusová R, Pospíchalová M. Toxicological risk of melamine and cyanuric acid in food and feed. Interdiscip Toxicol 2009;2(2):55-9. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">19. Reimschuessel R, Evans ER, Stine CB, Hasbrouck N, Mayer TD, Nochetto C, et al. Renal crystal formation after combined or sequential oral administration of melamine and cyanuric acid. Food Chem Toxicol 2010;48(10):2898- 906. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">20. Liu CC, Wu CF, Chen BH, Huang SP, Goggins W, Lee HH, et al. Low exposure to melamine increases the risk of urolithiasis in adults. Kidney Int 2011;80(7):746-52. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">21. Liu C-C, Hsieh T-J, Wu C-F, Lee CH, Tsai YC, Huang TY, et al. Interrelationship of environmental melamine exposure, biomarkers of oxidative stress and early kidney injury. J of Hazard Mater 2020;396:122726. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">22. Sathyanarayana S, Flynn JT, Messito MJ, Gross R, Whitlock KB, Kannan K, et al. Melamine and cyanuric acid exposure and kidney injury in US children. Environ Res 2019;171:18- 23. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">23. Sengupta P. The Laboratory Rat: Relating Its Age With Human’s. Int J Prev Med 2013;4(6):624-30. google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">24. FDA. Interim Safety and risk assessment of melamine and its analogues in food for humans [a]3 October 2008. Available from: URL: https://wayback.archive-it. org/7993/20170112012209/http://www.fda.gov/Food/ FoodborneIllnessContaminants/ChemicalContaminants/ ucm164522.htm. google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref25">
                        <label>25</label>
                        <mixed-citation publication-type="journal">25. Kotyk T, Dey N, Ashour AS, Balas-Timar D, Chakraborty S, Ashour AS, et al. Measurement of glomerulus diameter and Bowman’s space width of renal albino rats. Comput Methods Programs Biomed 2016;126:143-53. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref26">
                        <label>26</label>
                        <mixed-citation publication-type="journal">26. Márquez MG, Cabrera I, Serrano DJ, Sterin-Speziale N. Cell proliferation and morphometric changes in the rat kidney during postnatal development. Anat Embryol (Berl) 2002;205(5-6):431-40. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref27">
                        <label>27</label>
                        <mixed-citation publication-type="journal">27. Guo C, He Z, Wen L, Zhu L, Lu Y, Deng S, et al. Cytoprotective effect of trolox against oxidative damage and apoptosis in the NRK-52e cells induced by melamine. Cell Biol Int 2012;36(2):183-8. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref28">
                        <label>28</label>
                        <mixed-citation publication-type="journal">28. Kuo FC, Tseng YT, Wu SR, Wu MT, Lo YC. Mel activates NFkappaB/COX-2/PGE2 pathway and increases NADPH oxidase-dependent ROS production in macrophages and human embryonic kidney cells. Toxicol In Vitro 2013;27(6):1603-11. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref29">
                        <label>29</label>
                        <mixed-citation publication-type="journal">29. Lee IC, Ko JW, Park SH, Shin IS, Moon C, Kim SH, et al. Melamine and cyanuric acid co-exposure causes renal dysfunction and structural damage via MAPKs and mitochondrial signaling. Food Chem Toxicol 2016;96:254- 62. [CrossRef] google scholar</mixed-citation>
                    </ref>
                                    <ref id="ref30">
                        <label>30</label>
                        <mixed-citation publication-type="journal">30. Erisgin Z, Usta M. Does melamine exposure during infancy cause rhabdomyolysis? Biotech Histochem 2021;96(2):102- 10. [CrossRef] google scholar</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
